Medical News

RSS

BRAMS selected to provide DSP tools to investigate brain plasticity in humans

Sonomax Technologies Inc. has been selected by Montr-al's International Laboratory for Brain, Music and Sound Research to provide miniaturized, real-time, in-ear, digital signal processing devices to investigate experience-dependent brain plasticity in humans.

15 Apr 2010

Synergistic interactions of A2A Agonist and PDE Inhibitors as adjunctive therapy to GC for treating MM

“Glucocorticoids are a key component of combination therapy regimens in multiple myeloma and other hematological cancers. However, glucocorticoid use comes with substantial dose limiting toxicities. The ability to enhance glucocorticoid dependent effects while sparing associated toxicities may have important implications for the treatment of multiple myeloma and other B-cell malignancies”

15 Apr 2010

Targeted therapy MDV3100 is effective for patients with CRPC: Study

An experimental drug is showing promise for the treatment of men with an aggressive form of advanced prostate cancer. A new multicenter study has concluded that the targeted therapy MDV3100 is safe and effective for patients with castration-resistant prostate cancer, known for its poor prognosis and limited treatment options.

15 Apr 2010

Opexa Therapeutics presents key efficacy data on Tovaxin

Opexa Therapeutics, Inc., a company developing a novel T-cell therapy for multiple sclerosis, announced today that the Company presented key efficacy data at the American Academy of Neurology 62nd Annual Meeting held in Toronto, Canada.

15 Apr 2010

ICGC: New era of personalised medicine for cancer patients

Published online today in Nature, a paper authored by over 200 members of the International Cancer Genome Consortium describes the beginnings of a Brave New World, a new era of personalised medicine for cancer patients.

15 Apr 2010

ProCure Proton Therapy Center treats cancer patients with proton therapy technology

The world's first inclined beam treatment room is open and treating patients at the ProCure Proton Therapy Center in Oklahoma City. The third of four treatment rooms at the Oklahoma Center is treating a wide range of tumors with proton therapy, an important alternative to X-ray radiation in treating cancer.

15 Apr 2010

New findings point to potential dysfunctional learning process in chronic pain patients

New research reveals why a stimulus that healthy human subjects perceive as a reward might be processed quite differently in the brains of humans suffering from chronic pain.

15 Apr 2010

States respond to health law with lawsuits, policy shifts

"The insurance commissioner of Georgia has chosen not to comply with a federal request to create a state pool for high-risk insurance plans, opening a new front in the resistance by state Republican officials to the new federal health care law." The commissioner is a Republican candidate for governor (R. Brown, 4/13).

15 Apr 2010

New iVAS inflatable vertebral augmentation system released for VCFs

Stryker's Interventional Spine business unit today announced the release of its iVAS inflatable vertebral augmentation system, a minimally invasive device cleared for use in treating vertebral compression fractures.

15 Apr 2010

Global maternal deaths decreased by more than 35% between 1980 and 2008, study finds

The number of maternal deaths around the world has decreased from more than 500,000 in 1980 to an estimated 342,900 in 2008, according to a Lancet study published online on Monday, the BBC reports.

15 Apr 2010

MRI technology depicts women's anxiety of getting fat

A group of women in a new study seemed unlikely to have body image issues - at least their responses on a tried-and-true psychological screening presented no red flags.

15 Apr 2010

$SBUMC adds Toshiba Aquilion ONE \320-detector row CT system with pediatric imaging capabilities$

SBUMC adds Toshiba Aquilion ONE \320-detector row CT system with pediatric imaging capabilities

A new state-of-the art computed tomography (CT) scanner that provides physicians with precise images of internal organs with a single rotation of the gantry is now in operation at Stony Brook University Medical Center (SBUMC), adding to the hospital's advanced scanner technology.

15 Apr 2010

Synosia Therapeutics presents data from phase 2a clinical study of SYN-115 in PD

Synosia Therapeutics today announced the presentation of data from a phase 2a clinical study of the company's adenosine 2a receptor antagonist (SYN-115) in Parkinson's disease. The data demonstrate that SYN-115 significantly improves measures of motor and non-motor function in patients with Parkinson's disease either alone or in combination with levodopa.

15 Apr 2010

Brain regions play a fundamental role in empathetic and violent situations

"Just as our species could be considered the most violent, since we are capable of serial killings, genocide and other atrocities, we are also the most empathetic species, which would seem to be the other side of the coin", Luis Moya Albiol, lead author of the study and a researcher at the UV, tells SINC.

15 Apr 2010

Cegedim Dendrite announces global SaaS CRM agreement with UCB

Cegedim Dendrite, the world's leading provider of life-sciences specific Customer Relationship Solutions, has signed a global SaaS CRM agreement with biopharmaceutical company UCB.

15 Apr 2010

Research team to receive AACR Team Science Award

The fourth annual American Association for Cancer Research Team Science Award will be given to Dana-Farber/Harvard Cancer Center Thoracic Oncology Research Team at the AACR 101st Annual Meeting 2010. This research team is comprised of interdisciplinary investigators from the Dana-Farber Cancer Institute, Brigham and Women's Hospital, Massachusetts General Hospital, Beth Israel Deaconess Medical Center and Harvard Medical School.

15 Apr 2010

New findings may aid in developing medications for atherosclerosis and insulin resistance

Scientists from Eastern Virginia Medical School (EVMS) recently presented preliminary research findings that identify a specific gene as a potential new target for treating obesity-related diseases.

15 Apr 2010

Phase II clinical study examining CTT's Calmare pain therapy medical device completed

Competitive Technologies, Inc. announced today that Thomas J. Smith, MD FACP, and co-investigator Patrick J. Coyne, MSN, APRN, FAAN, of Virginia Commonwealth University's Massey Cancer Center have completed their open Phase II clinical study examining CTT's Calmare pain therapy medical device's efficacy treating patients suffering with severe pain from chemotherapy induced peripheral neuropathy.

15 Apr 2010

Albert Einstein College of Medicine receives grant to study link between housing status and cardiovascular health

Albert Einstein College of Medicine of Yeshiva University has been awarded $750,000 by the John D. and Catherine T. MacArthur Foundation to study the impact of housing on the cardiovascular health of Latinos in the Bronx.

15 Apr 2010

POZEN enters Settlement Agreement with Teva over generic Treximet ANDA patent infringement litigation

POZEN Inc., today announced that it has entered into a Settlement Agreement with Teva Pharmaceuticals USA, Inc. (Teva) to resolve a U.S. patent infringement suit related to Teva's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) to market a generic version of Treximet® (sumatriptan/naproxen sodium) marketed by POZEN's exclusive U.S. licensee, GlaxoSmithKline.

15 Apr 2010

Medical News

BRAMS selected to provide DSP tools to investigate brain plasticity in humans

Synergistic interactions of A2A Agonist and PDE Inhibitors as adjunctive therapy to GC for treating MM

Targeted therapy MDV3100 is effective for patients with CRPC: Study

Opexa Therapeutics presents key efficacy data on Tovaxin

ICGC: New era of personalised medicine for cancer patients

ProCure Proton Therapy Center treats cancer patients with proton therapy technology

New findings point to potential dysfunctional learning process in chronic pain patients

States respond to health law with lawsuits, policy shifts

New iVAS inflatable vertebral augmentation system released for VCFs

Global maternal deaths decreased by more than 35% between 1980 and 2008, study finds

MRI technology depicts women's anxiety of getting fat

SBUMC adds Toshiba Aquilion ONE \320-detector row CT system with pediatric imaging capabilities

Synosia Therapeutics presents data from phase 2a clinical study of SYN-115 in PD

Brain regions play a fundamental role in empathetic and violent situations

Cegedim Dendrite announces global SaaS CRM agreement with UCB

Research team to receive AACR Team Science Award

New findings may aid in developing medications for atherosclerosis and insulin resistance

Phase II clinical study examining CTT's Calmare pain therapy medical device completed

Albert Einstein College of Medicine receives grant to study link between housing status and cardiovascular health

POZEN enters Settlement Agreement with Teva over generic Treximet ANDA patent infringement litigation

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News